Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements
21 Febbraio 2019 - 4:45PM
Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it
received notice from The Nasdaq Stock Market LLC indicating that
the Company has regained compliance with the minimum bid price
requirement under NASDAQ Listing Rule 5550(a)(2) (the "Bid Price
Rule") for continued listing on The NASDAQ Capital Market.
Accordingly, the Company has regained compliance with the Bid Price
Rule and NASDAQ considers the matter closed.
Ohr Pharmaceutical Contact: Investor
Relations
OP: 212-682-8452ir@ohrpharmaceutical.com
Grafico Azioni Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Ohr Pharmaceuticals, Inc. (NASDAQ): 0 articoli recenti
Più Articoli Notizie